Skip to main content
Unit of study_

PHAR5927: Professional Practice

Semester 2, 2022 [Normal day] - Camperdown/Darlington, Sydney

This unit of study consolidates previous units from the entire Master of Pharmacy curriculum through the presentation and solving of clinical and ethical problems. It has a focus on knowledge application in a simulated pharmacy workplace and includes professional services. Case based role-plays will be used to develop students' communication and clinical skills for future interactions with patients, doctors, other health professionals and pharmacy colleagues. The unit consists of lectures, on-line learning and simulated case-based competency assessment and learning. Further dispensing skills will also be incorporated into this unit of study.

Unit details and rules

Unit code PHAR5927
Academic unit Pharmacy
Credit points 9
Prohibitions
? 
None
Prerequisites
? 
None
Corequisites
? 
None
Assumed knowledge
? 

None

Available to study abroad and exchange students

No

Teaching staff

Coordinator Rebekah Moles, rebekah.moles@sydney.edu.au
Lecturer(s) Rebekah Moles, rebekah.moles@sydney.edu.au
Type Description Weight Due Length
Final exam (Live+ supervised) Type A final exam hurdle task Forensics Exam
MCQ and Short answer.
0% Formal exam period 1 hour
Outcomes assessed: LO6
Skills-based evaluation Vaccinations
You will have a vaccination workshop towards the end of semester
0% Multiple weeks 9 hours
Outcomes assessed: LO2 LO6 LO5
Skills-based evaluation hurdle task group assignment Health Care Collaboration
Inter-professional group task in week 3 where teams work on a case.
0% Week 03
Due date: 19 Aug 2022 at 23:00
8 hours
Outcomes assessed: LO1 LO4 LO3 LO2
Participation hurdle task Hospital Conference
Hospital Conference at Westmead hospital in week 5
0% Week 05
Due date: 02 Sep 2022 at 23:00
8 hours
Outcomes assessed: LO2 LO5 LO4 LO3
Assignment hurdle task HMR
HMR history taking will be in week 8 and report will be due Midnight Sunday
30% Week 08
Due date: 23 Sep 2022 at 23:59
8 hours
Outcomes assessed: LO2 LO3 LO4
Participation hurdle task Device Workshop
Device workshop will occur in week 9 where students need to visit stations.
0% Week 09
Due date: 07 Oct 2022 at 23:00
3-4 hours
Outcomes assessed: LO2 LO5 LO4
Participation hurdle task IPL
IPL task with nursing week 5 and 11.
0% Week 11 8 hours.
Outcomes assessed: LO1 LO4 LO3 LO2
Presentation group assignment Mock Clinic
Group Pitch Mock clinic -week 7 present clinic - week 13
30% Week 13
Due date: 31 Oct 2022 at 13:00
2x 20mins
Outcomes assessed: LO1 LO2 LO3 LO4 LO5
Assignment hurdle task CPD portfolio
Collation of CPD activities in a portfolio of 10 or more points.
0% Week 13
Due date: 11 Nov 2022 at 22:00
5-10 hours
Outcomes assessed: LO2 LO3 LO4 LO5
Skills-based evaluation hurdle task Simulations
You will be assigned to 8 simulated cases to be performed in the classroom
40% Weekly 30mins X 8
Outcomes assessed: LO2 LO6 LO5 LO4 LO3
hurdle task = hurdle task ?
group assignment = group assignment ?
Type A final exam = Type A final exam ?

Assessment summary

  • Tutorial simulated case assessments: Students will need to handle 8 competency tasks (5% each) individually over the semester. Students are provided up to 3 opportunities to pass each task if required, with initial mark counting towards their cumulative assessment. 
  • Medication review: A medication review interview and report are to be undertaken and submitted for formal marking in week 8. Marks will be deducted for late submissions according to university policy. A second attempt will be offerred to students that receive less than 50% on first attempt.
  • Vaccination training course  students must complete 9 online pre-work modules, attend a 3 hour lecture/seminar and a 5 hour practical workshop. In order to receive the certificate of vaccination training students must successfully complete all the online module as well as the coursework.
  • Mock Clinic: Students will work in teams to design a clinic. This task is integrated with the task in PHAR5925. A pitch presentaion will occur in week 7 and the clinic will be presented in week 13. Peer assessment (relative performance factor) will be applied to moderate the groupwork marks. Peer assessment will be completed online to obtain a factor between 0-1, and will be according to an agreed set of criteria established by groups
  • Forensics Exam: The Forensics exam will be delivered online and consist of questions relating to the Poisons and Therapeutic Goods legislation in NSW and/or pharmacy relevant law. Students must achieve a minimum mark of 65% to pass the unit. Students who do not achieve this minimum mark will be offered the opportunity to attempt an additional assessment on 25th November 2022 in the formal exam period.
  • IPL:Students will complete an IPL session with nursing in week 5 and 11. This will involve online lecture/preparation and an interactive session with nursing students on campus.
  • Hospital Conference: Students are required to attend a hospital conference session on Friday week 5 at Westmead Hospital. Attendance is compulsary. Students that cannot attend this session due to misadventure may be offerred an alternative task to complete on approval of special consideration.
  • Device Workshop: Students are required to attend a Device workshop on Friday week 9. Attendance is compulsary. Students that cannot attend this session due to misadventure may be offerred an alternative task to complete on approval of special consideration.
  • Health Collaboration Challenge: Students are required to attend the HCC team meetings. Attendance is compulsary. Students that cannot attend this session due to misadventure may be offerred an alternative task to complete on approval of special consideration.
  • CPD Portfolio: Students must obtain and document participating in a minimum of 10 continuing professional development points above and beyond the standard lectures, workshops and tutorials within the prescribed university of sydney MPharm units of study. Students are to submit this portfolio by Friday week 13.
  • All assessment components must be passed (ie 50%) to satisfy the requirements of the unit of study. A fail in compulsory assessment will result in an overall fail (45) for this unit of study.
  • Supplementary Yr assessments: Students may be offered re-assessment of compulsory-to-pass assessments in the RE1 or RE2 formal exam periods. For more information see Canvas. 

  • Repeating students: Exemption from all compulsory components for students repeating PHAR5927 will not be granted.

Assessment criteria

Result name

Mark range

Description

High distinction

85 - 100

At HD level, a student demonstrates an aptitude for the subject and a well-developed understanding of the unit material. A ‘High Distinction’ reflects exceptional achievement and is awarded to students who demonstrate the ability to apply their subject knowledge and understanding to produce original solutions for novel or highly complex problems and/or comprehensive critical discussions of theoretical concepts. 

Distinction

75 - 84

At DI level, a student demonstrates an aptitude for the subject and a well-developed understanding of the units material. A ‘Distinction’ reflects excellent achievement and is awarded to a student who demonstrates an ability to apply their subject knowledge and understanding of the subject to produce good solutions for challenging problems and/or a reasonably well-developed critical analysis of theoretical concepts. 

Credit

65 - 74

At CR level, a student demonstrates a good command and knowledge of the unit material. A ‘Credit’ reflects solid achievement and is awarded to a student who has a broad general understanding of the units material and can solve routine problems and/ or identify and superficially discuss theoretical concepts. 

 

Pass

50 - 64

At PS level, a student demonstrates proficiency in the material. A ‘Pass’ reflects satisfactory adequately referencing the original source of the work. 

Fail

0 - 49

When you don’t meet the learning outcomes of the unit to a satisfactory standard.

For more information see guide to grades.

Late submission

In accordance with University policy, these penalties apply when written work is submitted after 11:59pm on the due date:

  • Deduction of 5% of the maximum mark for each calendar day after the due date.
  • After ten calendar days late, a mark of zero will be awarded.

This unit has an exception to the standard University policy or supplementary information has been provided by the unit coordinator. This information is displayed below:

For submitted assessments 5% will be deducted for each day the assessment task is late. Non submission of peer assessment will result in a factor of zero (0) being applied to the non-submitter’s groupwork mark.

Academic integrity

The Current Student website  provides information on academic integrity and the resources available to all students. The University expects students and staff to act ethically and honestly and will treat all allegations of academic integrity breaches seriously.  

We use similarity detection software to detect potential instances of plagiarism or other forms of academic integrity breach. If such matches indicate evidence of plagiarism or other forms of academic integrity breaches, your teacher is required to report your work for further investigation.

You may only use artificial intelligence and writing assistance tools in assessment tasks if you are permitted to by your unit coordinator, and if you do use them, you must also acknowledge this in your work, either in a footnote or an acknowledgement section.

Studiosity is permitted for postgraduate units unless otherwise indicated by the unit coordinator. The use of this service must be acknowledged in your submission.

Simple extensions

If you encounter a problem submitting your work on time, you may be able to apply for an extension of five calendar days through a simple extension.  The application process will be different depending on the type of assessment and extensions cannot be granted for some assessment types like exams.

Special consideration

If exceptional circumstances mean you can’t complete an assessment, you need consideration for a longer period of time, or if you have essential commitments which impact your performance in an assessment, you may be eligible for special consideration or special arrangements.

Special consideration applications will not be affected by a simple extension application.

Using AI responsibly

Co-created with students, AI in Education includes lots of helpful examples of how students use generative AI tools to support their learning. It explains how generative AI works, the different tools available and how to use them responsibly and productively.

WK Topic Learning activity Learning outcomes
Multiple weeks A series of lectures on Pharmacy Forensics, Pharmacy Management, Clinical topics as well as careers will be posted online throughout the semester. Lecture and tutorial (20 hr) LO2 LO3 LO4 LO5 LO6
8 competency-based simulations will occur in the classroom over the semester, as well as a simulated medication review and report. You will also simulate vaccination. Simulation laboratory (70 hr) LO2 LO3 LO4 LO5 LO6
Mock Clinic pitch will be done in Week 7 in combination with PHAR 5725. Presentation of Clinic will be in Week 13. Presentation (16 hr) LO1 LO2 LO3 LO4 LO5
IPL activities include 2 tutorials with Nursing as well as the Health Care Collaboration. A Hospital conference at Westmead is also timetabled, as well as a device workshop Workshop (28 hr) LO1 LO2 LO3 LO4
Ongoing Independent study for med review, presentation and forensics Independent study (41 hr) LO1 LO2 LO3 LO4 LO5 LO6

Attendance and class requirements

Attendance: In accordance with the Master of Pharmacy Course resolutions on Attendance Requirements, students must attend a minimum of 85% Simulated tutorials, workshops, IPL, Forensics and Mock Clinics to satisfy attendance requirements for this unit of study. For more information see: 

https://www.sydney.edu.au/handbooks/medicine_health_PG/coursework_pz/pharmacy.shtml

If a tutorial/ lab/workshop is missed due to illness or misadventure, students are to submit a special consideration application along with supporting documentation, and maybe offerred an alternative task. 

Study commitment

Typically, there is a minimum expectation of 1.5-2 hours of student effort per week per credit point for units of study offered over a full semester. For a 9 credit point unit, this equates to roughly 180-225 hours of student effort in total.

Learning outcomes are what students know, understand and are able to do on completion of a unit of study. They are aligned with the University's graduate qualities and are assessed as part of the curriculum.

At the completion of this unit, you should be able to:

  • LO1. Demonstrate Effective teamwork
  • LO2. Effectively communicate with consumers, peers and other health professionals
  • LO3. Identify and assess potential causes of medication related problems
  • LO4. Apply legal, ethical and clinical reasoning to manage medication related problems
  • LO5. Create and evaluate new pharmacy related services to assist patients in need of acute and chronic care
  • LO6. Demonstrate a working understanding of the legislation surrounding the supply of scheduled medicines in NSW

Graduate qualities

The graduate qualities are the qualities and skills that all University of Sydney graduates must demonstrate on successful completion of an award course. As a future Sydney graduate, the set of qualities have been designed to equip you for the contemporary world.

GQ1 Depth of disciplinary expertise

Deep disciplinary expertise is the ability to integrate and rigorously apply knowledge, understanding and skills of a recognised discipline defined by scholarly activity, as well as familiarity with evolving practice of the discipline.

GQ2 Critical thinking and problem solving

Critical thinking and problem solving are the questioning of ideas, evidence and assumptions in order to propose and evaluate hypotheses or alternative arguments before formulating a conclusion or a solution to an identified problem.

GQ3 Oral and written communication

Effective communication, in both oral and written form, is the clear exchange of meaning in a manner that is appropriate to audience and context.

GQ4 Information and digital literacy

Information and digital literacy is the ability to locate, interpret, evaluate, manage, adapt, integrate, create and convey information using appropriate resources, tools and strategies.

GQ5 Inventiveness

Generating novel ideas and solutions.

GQ6 Cultural competence

Cultural Competence is the ability to actively, ethically, respectfully, and successfully engage across and between cultures. In the Australian context, this includes and celebrates Aboriginal and Torres Strait Islander cultures, knowledge systems, and a mature understanding of contemporary issues.

GQ7 Interdisciplinary effectiveness

Interdisciplinary effectiveness is the integration and synthesis of multiple viewpoints and practices, working effectively across disciplinary boundaries.

GQ8 Integrated professional, ethical, and personal identity

An integrated professional, ethical and personal identity is understanding the interaction between one’s personal and professional selves in an ethical context.

GQ9 Influence

Engaging others in a process, idea or vision.

Outcome map

Learning outcomes Graduate qualities
GQ1 GQ2 GQ3 GQ4 GQ5 GQ6 GQ7 GQ8 GQ9

Alignment with Competency standards

Outcomes Competency standards
LO1
Performance Outcomes Framework - Australian Pharmacy Council - On successful completion of an approved pharmacy degree program - APC
2.1.b. engaging with all persons in a respectful, culturally appropriate, compassionate, responsive and empathetic manner
2.1.d. demonstrating appropriate communication and interpersonal behaviours
2.3. contributing to the interprofessional collaborative health care team in order to optimise patient outcomes by
2.3.a. demonstrating an understanding and appreciation of the roles of pharmacists and other members of the interprofessional collaborative care team
2.3.c. demonstrating appropriate teamwork behaviours
LO2
Performance Outcomes Framework - Australian Pharmacy Council - On successful completion of an approved pharmacy degree program - APC
2.1. communicating appropriately and effectively with a socially and culturally diverse range of people in a manner which inspires confidence and trust by
2.1.b. engaging with all persons in a respectful, culturally appropriate, compassionate, responsive and empathetic manner
2.1.d. demonstrating appropriate communication and interpersonal behaviours
2.2. documenting, communicating and recording relevant information, findings, decisions, recommendations and other information accurately and concisely, taking due account of privacy and confidentiality
2.3. contributing to the interprofessional collaborative health care team in order to optimise patient outcomes by
2.3.a. demonstrating an understanding and appreciation of the roles of pharmacists and other members of the interprofessional collaborative care team
2.3.b. creating and maintaining effective intra- and interprofessional relationships, and working in partnership to achieve negotiated, agreed-upon objectives
2.3.c. demonstrating appropriate teamwork behaviours
2.3.d. demonstrating appropriate communication at transition points in patient care to reduce risks to patients and ensure safe and effective continuity of patient care
2.4. collaborating with patients, carers and other clients in shared decision-making by
2.4.a. supporting the rights of patients, carers and other clients to access relevant information and participate in decisions relating to their care
2.4.b. respecting their choices
3.1.d. making decisions which are tailored to the person’s individual circumstances, and reflect a balanced consideration of both the potential benefits and potential harms
3.10. facilitating patient self-management of health through education, intervention, monitoring and health promotion services in order to optimise patient health outcomes and wellbeing, and reduce the risk of complications
3.11. responding to the needs of individuals and communities by advocating with and for them to optimise health and societal outcomes
3.17. providing appropriate tailored counselling, information and education to enable safe and effective medication, disease state and lifestyle management
3.2. making and prioritising recommendations to manage health, medical and medication needs of patients, including both pharmacological and nonpharmacological strategies, based on the Quality Use of Medicines Framework and the best available evidence
3.5. demonstrating the delivery of person-centred care including
3.5.a. respecting the personal characteristics, rights, preferences, values, beliefs, needs and diversity of patients, carers and other persons
3.5.b. maintaining privacy and confidentiality in interactions with patients, carers and other persons
3.5.d. ensuring that the best interests of patients, carers and other persons are foremost in the provision of care
3.5.e. ensuring that patients, carers and other persons are provided with sufficient information and advice to enable them to consider options and give informed consent where appropriate
3.5.f. ensuring that informed consent is obtained, respected and appropriately recorded when appropriate
3.6. obtaining relevant health, medical and medication information from patients, carers and other clients
3.7. assessing current health, medical and medication histories and profiles of patients
3.9. recommending appropriate monitoring of the outcomes of health, medical and medication management plans and recommending adjustments to them where appropriate in collaboration with patients, carers and other health team members
4.3. demonstrating self-awareness and self-regulation of personal attributes, strengths and weaknesses which may affect professional performance and/or personal development
5.1. demonstrating skills as a role model, facilitator and/or mentor which are appropriate to their context
5.5. accessing, using, adapting and sharing information and/or other technologies to meet the needs of current and emerging professional practice
LO3
Performance Outcomes Framework - Australian Pharmacy Council - On successful completion of an approved pharmacy degree program - APC
1.1. promoting both the best interests and safety of patients and the public
1.3. recognising the presence and causes of health inequities and disparities, including the impact of social determinants of health
1.4.a. demonstrating contemporary knowledge and application of legal requirements relating to community and hospital pharmacy practice within their jurisdiction
1.4.b. demonstrating awareness of the processes for maintaining contemporary familiarity with key legislative instruments
1.5. practising ethically and with integrity by
1.5.a. identifying potential ethical issues and dilemmas, including conflicts of interest, relating to practice
1.5.b. considering alternative strategies and choosing an appropriate course of action in response to ethical issues and dilemmas
1.5.c. demonstrating awareness of relevant professional codes, guidelines and standards and their content
1.5.d. recognising and formulating strategies to respond appropriately to situations which fall outside their expected scope of practice or competence
1.6. demonstrating a proactive and reflective approach to developing their own professional competence and expertise
1.7. demonstrating awareness of appropriate change management principles and strategies
2.2. documenting, communicating and recording relevant information, findings, decisions, recommendations and other information accurately and concisely, taking due account of privacy and confidentiality
2.3.a. demonstrating an understanding and appreciation of the roles of pharmacists and other members of the interprofessional collaborative care team
2.3.b. creating and maintaining effective intra- and interprofessional relationships, and working in partnership to achieve negotiated, agreed-upon objectives
2.3.d. demonstrating appropriate communication at transition points in patient care to reduce risks to patients and ensure safe and effective continuity of patient care
3.1. formulating appropriate and effective actions and recommendations which support safe, rational and cost-effective use of medicines and other healthcare options and optimise socially accountable person-centred care by
3.1.a. applying relevant underpinning knowledge
3.1.b. using a systematic approach to access, critically evaluate and apply relevant evidence
3.1.c. applying effective critical thinking, reasoning and problem-solving strategies to conceptualise problems, formulate a range of potential solutions, and support decision-making
3.1.d. making decisions which are tailored to the person’s individual circumstances, and reflect a balanced consideration of both the potential benefits and potential harms
3.10. facilitating patient self-management of health through education, intervention, monitoring and health promotion services in order to optimise patient health outcomes and wellbeing, and reduce the risk of complications
3.11. responding to the needs of individuals and communities by advocating with and for them to optimise health and societal outcomes
3.12. consistently making accurate arithmetic calculations relating to health care
3.14. dispensing medicines safely and accurately in accordance with current legislation, scope of practice, PharmBA Guidelines and other relevant jurisdictional requirements to optimise patient outcomes
3.16. demonstrating awareness of the appropriate conditions for secure and safe storage and distribution of medications to ensure stability and efficacy
3.17. providing appropriate tailored counselling, information and education to enable safe and effective medication, disease state and lifestyle management
3.2. making and prioritising recommendations to manage health, medical and medication needs of patients, including both pharmacological and nonpharmacological strategies, based on the Quality Use of Medicines Framework and the best available evidence
3.20. providing evidence-based screening, assessment, prevention and referral services to detect and manage potential risk of adverse medical conditions and outcomes
3.21. demonstrating the delivery of harm minimisation approaches and strategies to reduce harm to patients and the community from misuse of legal and illegal drugs
3.3. prescribing medications in accordance with current jurisdiction-specific legislation, scope of practice and PharmBA Guidelines
3.4. carrying out systematic medication reviews, informed by the Quality Use of Medicines Framework, in order to identify and resolve potential medication-related issues and optimise the impact of medications on health outcomes in collaboration with patients, carers and other members of the health care team
3.5. demonstrating the delivery of person-centred care including
3.5.a. respecting the personal characteristics, rights, preferences, values, beliefs, needs and diversity of patients, carers and other persons
3.5.c. optimising as far as is practicable the physical environment in which care takes place
3.5.d. ensuring that the best interests of patients, carers and other persons are foremost in the provision of care
3.5.e. ensuring that patients, carers and other persons are provided with sufficient information and advice to enable them to consider options and give informed consent where appropriate
3.6. obtaining relevant health, medical and medication information from patients, carers and other clients
3.7. assessing current health, medical and medication histories and profiles of patients
3.8. formulating health, medical and medication management plans in collaboration with patients, carers and other health team members
3.9. recommending appropriate monitoring of the outcomes of health, medical and medication management plans and recommending adjustments to them where appropriate in collaboration with patients, carers and other health team members
4.10. demonstrating awareness of, and complying with appropriate policies, processes and protocols
4.11. demonstrating skills in the identification, assessment, monitoring, mitigation and management of risk
4.4. demonstrating awareness of the signs which indicate that a potential risk to public safety may exist if observed in another practitioner, and formulating appropriate responses including support, advice, assistance, referral or reporting where necessary
4.5. recognising situations likely to compromise performance and developing effective strategies to minimise their impact
4.6. evaluating personal health and wellbeing status, identifying situations where health or wellbeing may be challenged, and developing appropriate strategies and mechanisms to minimise their impact on personal and professional life
4.7. demonstrating effective leadership skills, including taking the initiative when appropriate, managing own roles, and understanding and accepting appropriate responsibility and accountability for organising, planning, prioritising, influencing and negotiating within a team context
5.3. demonstrating awareness of the inherent complexity, ambiguity and uncertainty of contemporary and future professional practice
5.4. demonstrating skills in research and inquiry, including
5.4.a. formulating questions
5.4.b. identifying and critically appraising relevant source materials
5.4.c. undertaking relevant investigations, where appropriate
5.4.d. drawing conclusions by synthesising the results of research and inquiry activities
5.4.e. reporting and disseminating the outcomes appropriately
5.4.f. identifying ways in which the outcomes can be applied to practice
5.5. accessing, using, adapting and sharing information and/or other technologies to meet the needs of current and emerging professional practice
LO4
Performance Outcomes Framework - Australian Pharmacy Council - On successful completion of an approved pharmacy degree program - APC
1.1. promoting both the best interests and safety of patients and the public
1.2. promoting and advocating for cultural safety, respect and responsiveness, particularly in relation to Aboriginal and Torres Strait Islander and/or Māori peoples
1.3. recognising the presence and causes of health inequities and disparities, including the impact of social determinants of health
1.4. practising legally by
1.4.a. demonstrating contemporary knowledge and application of legal requirements relating to community and hospital pharmacy practice within their jurisdiction
1.4.b. demonstrating awareness of the processes for maintaining contemporary familiarity with key legislative instruments
1.5. practising ethically and with integrity by
1.5.a. identifying potential ethical issues and dilemmas, including conflicts of interest, relating to practice
1.5.b. considering alternative strategies and choosing an appropriate course of action in response to ethical issues and dilemmas
1.5.c. demonstrating awareness of relevant professional codes, guidelines and standards and their content
1.5.d. recognising and formulating strategies to respond appropriately to situations which fall outside their expected scope of practice or competence
1.6. demonstrating a proactive and reflective approach to developing their own professional competence and expertise
1.7. demonstrating awareness of appropriate change management principles and strategies
1.8. accepting personal responsibility and accountability for decisions and actions in simulated and/or work-integrated learning environments
1.9. upholding and maintaining the reputation and value of the profession
3.14. dispensing medicines safely and accurately in accordance with current legislation, scope of practice, PharmBA Guidelines and other relevant jurisdictional requirements to optimise patient outcomes
3.15. preparing and supplying extemporaneously compounded medications safely and accurately in accordance with current legislation, scope of practice, PharmBA Guidelines and other relevant jurisdictional requirements
3.16. demonstrating awareness of the appropriate conditions for secure and safe storage and distribution of medications to ensure stability and efficacy
3.2. making and prioritising recommendations to manage health, medical and medication needs of patients, including both pharmacological and nonpharmacological strategies, based on the Quality Use of Medicines Framework and the best available evidence
3.3. prescribing medications in accordance with current jurisdiction-specific legislation, scope of practice and PharmBA Guidelines
3.4. carrying out systematic medication reviews, informed by the Quality Use of Medicines Framework, in order to identify and resolve potential medication-related issues and optimise the impact of medications on health outcomes in collaboration with patients, carers and other members of the health care team
3.5.a. respecting the personal characteristics, rights, preferences, values, beliefs, needs and diversity of patients, carers and other persons
3.5.b. maintaining privacy and confidentiality in interactions with patients, carers and other persons
3.5.c. optimising as far as is practicable the physical environment in which care takes place
3.5.e. ensuring that patients, carers and other persons are provided with sufficient information and advice to enable them to consider options and give informed consent where appropriate
3.5.f. ensuring that informed consent is obtained, respected and appropriately recorded when appropriate
4.1. undertaking regular reflection as a means of enhancing learning and practice
4.10. demonstrating awareness of, and complying with appropriate policies, processes and protocols
4.2. demonstrating awareness of professional limitations and adopting appropriate strategies where necessary, including additional professional education and/or referral of patients to other health care professionals
4.3. demonstrating self-awareness and self-regulation of personal attributes, strengths and weaknesses which may affect professional performance and/or personal development
4.4. demonstrating awareness of the signs which indicate that a potential risk to public safety may exist if observed in another practitioner, and formulating appropriate responses including support, advice, assistance, referral or reporting where necessary
4.5. recognising situations likely to compromise performance and developing effective strategies to minimise their impact
4.6. evaluating personal health and wellbeing status, identifying situations where health or wellbeing may be challenged, and developing appropriate strategies and mechanisms to minimise their impact on personal and professional life
4.7. demonstrating effective leadership skills, including taking the initiative when appropriate, managing own roles, and understanding and accepting appropriate responsibility and accountability for organising, planning, prioritising, influencing and negotiating within a team context
4.8. demonstrating awareness of the importance of, and strategies for, promoting responsible and socially accountable stewardship of health care resources
4.9. promoting quality assurance and continuous quality improvement strategies through utilising skills in collaboration, critical thinking, curiosity and creativity
5.4.b. identifying and critically appraising relevant source materials
LO5
Performance Outcomes Framework - Australian Pharmacy Council - On successful completion of an approved pharmacy degree program - APC
3.18. assessing ambulatory conditions and recommending appropriate management approaches, including pharmacological, non-pharmacological and referral options where appropriate
3.19. demonstrating the delivery of measures designed to enhance adherence with dosage regimens and support safe and effective administration of medications
3.20. providing evidence-based screening, assessment, prevention and referral services to detect and manage potential risk of adverse medical conditions and outcomes
3.21. demonstrating the delivery of harm minimisation approaches and strategies to reduce harm to patients and the community from misuse of legal and illegal drugs
3.22. endorsing and participating in health promotion activities, health services and public health initiatives intended to maintain and improve health
4.1. undertaking regular reflection as a means of enhancing learning and practice
4.7. demonstrating effective leadership skills, including taking the initiative when appropriate, managing own roles, and understanding and accepting appropriate responsibility and accountability for organising, planning, prioritising, influencing and negotiating within a team context
4.8. demonstrating awareness of the importance of, and strategies for, promoting responsible and socially accountable stewardship of health care resources
4.9. promoting quality assurance and continuous quality improvement strategies through utilising skills in collaboration, critical thinking, curiosity and creativity
5. Domain 5 Research, inquiry and education
5.1. demonstrating skills as a role model, facilitator and/or mentor which are appropriate to their context
5.2. demonstrating awareness of effective processes for facilitating learning, including aims, learning outcomes, learning activities, assessment and feedback
5.3. demonstrating awareness of the inherent complexity, ambiguity and uncertainty of contemporary and future professional practice
5.4. demonstrating skills in research and inquiry, including
5.4.a. formulating questions
5.4.b. identifying and critically appraising relevant source materials
5.4.c. undertaking relevant investigations, where appropriate
5.4.d. drawing conclusions by synthesising the results of research and inquiry activities
5.4.e. reporting and disseminating the outcomes appropriately
5.4.f. identifying ways in which the outcomes can be applied to practice
5.5. accessing, using, adapting and sharing information and/or other technologies to meet the needs of current and emerging professional practice
LO6
Performance Outcomes Framework - Australian Pharmacy Council - On successful completion of an approved pharmacy degree program - APC
1.5.a. identifying potential ethical issues and dilemmas, including conflicts of interest, relating to practice
1.5.b. considering alternative strategies and choosing an appropriate course of action in response to ethical issues and dilemmas
1.5.c. demonstrating awareness of relevant professional codes, guidelines and standards and their content
3.13. administering injectable formulations in accordance with current jurisdictionspecific legislation, scope of practice and PharmBA Guidelines
3.14. dispensing medicines safely and accurately in accordance with current legislation, scope of practice, PharmBA Guidelines and other relevant jurisdictional requirements to optimise patient outcomes
3.3. prescribing medications in accordance with current jurisdiction-specific legislation, scope of practice and PharmBA Guidelines

This section outlines changes made to this unit following staff and student reviews.

This unit has merged the Mock clinic assessment with the assessment in PHAR5725 so as students can work in the same groups on related topics. This has been done based on student feedback. A CPD portfolio has been added to familiarize students with compulsory requirements of being a registered professional pharmacist.

Work, health and safety

Vaccinations workshops will be run by trained experts. PPE will be provided to each student including sharps containers and gloves. All inicidents will be reported immediately in risk ware as per WHS policy

Disclaimer

The University reserves the right to amend units of study or no longer offer certain units, including where there are low enrolment numbers.

To help you understand common terms that we use at the University, we offer an online glossary.